Skip to main content
Erschienen in: Endocrine 2/2009

01.10.2009 | Original Article

The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome

verfasst von: Hyejin Lee, Jee-Young Oh, Yeon-Ah Sung, Hyewon Chung, Wha Young Cho

Erschienen in: Endocrine | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Insulin resistance and hyperinsulinemia play important roles in the pathogenesis of polycystic ovary syndrome (PCOS). In addition, some women with PCOS have been shown to have insulin secretory defects and can be predicted to be at an increased risk for glucose intolerance. We performed the present study to determine the prevalence and risk factors for glucose intolerance in Korean women with PCOS. We consecutively recruited 194 women with PCOS diagnosed by American Society for Reproductive Medicine/European Society of Human Reproduction and Embryology (ASRM/ESHRE) criteria. Anthropometric measures, 75 g oral glucose tolerance test (OGTT), and measurement of insulin sensitivity (insulin mediated glucose uptake; IMGU) using euglycemic hyperinsulinemic clamp technique were performed. In women with PCOS, the prevalence of impaired glucose tolerance (IGT) and/or impaired fasting glucose (IFG) was 17.0% and type 2 diabetes 1.0%, and in lean women with PCOS, the prevalence of IGT and/or IFG was 5.9%. The prevalence of glucose intolerance was 28-fold higher in women with PCOS, and 9.8-fold higher in lean women with PCOS compared to age-matched Korean women. Women with glucose intolerance had higher BMI, waist circumference, free testosterone, fasting insulin, 2-h post-load insulin, total cholesterol, LDL cholesterol, triglyceride and lower sex hormone binding globulin and IMGU than women with normal glucose tolerance (NGT) (P < 0.05). IMGU was the most powerful predictor for glucose intolerance after adjustment for age, BMI, waist circumference, and hyperandrogenemia. The 2-h OGTT was the best screening measure for glucose intolerance and diagnosis of diabetes in women with PCOS. Young Korean women with PCOS have high prevalence for glucose intolerance and type 2 diabetes, and insulin resistance is the most important factor associated with glucose intolerance.
Literatur
1.
Zurück zum Zitat A. Dunaif, A. Thomas, Current concepts in the polycystic ovary syndrome. Annu. Rev. Med. 52, 401–419 (2001)CrossRefPubMed A. Dunaif, A. Thomas, Current concepts in the polycystic ovary syndrome. Annu. Rev. Med. 52, 401–419 (2001)CrossRefPubMed
2.
Zurück zum Zitat A. Dunaif, Insulin resistance, the polycystic ovary syndrome: mechanism, implications for pathogenesis. Endocr. Rev. 18, 774–800 (1997)CrossRefPubMed A. Dunaif, Insulin resistance, the polycystic ovary syndrome: mechanism, implications for pathogenesis. Endocr. Rev. 18, 774–800 (1997)CrossRefPubMed
3.
Zurück zum Zitat R.S. Legro, A.R. Kunselman, W.C. Dodson, A. Dunaif, Prevalence predictors of risk for type 2 diabetes mellitus, impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J. Clin. Endocrinol. Metab. 84, 165–169 (1999)CrossRefPubMed R.S. Legro, A.R. Kunselman, W.C. Dodson, A. Dunaif, Prevalence predictors of risk for type 2 diabetes mellitus, impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J. Clin. Endocrinol. Metab. 84, 165–169 (1999)CrossRefPubMed
4.
Zurück zum Zitat S. Lillioja, D.M. Mott, M. Spraul, R. Ferraro, J.E. Foley, E. Ravussin, W.C. Knowler, P.H. Bennett, C. Bogardus, Insulin resistance, insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N. Engl. J. Med. 329, 1988–1992 (1993)CrossRefPubMed S. Lillioja, D.M. Mott, M. Spraul, R. Ferraro, J.E. Foley, E. Ravussin, W.C. Knowler, P.H. Bennett, C. Bogardus, Insulin resistance, insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N. Engl. J. Med. 329, 1988–1992 (1993)CrossRefPubMed
5.
Zurück zum Zitat D.A. Ehrmann, R.B. Barnes, R.L. Rosenfield, M.K. Cavaghan, J. Imperial, Prevalence of impaired glucose tolerance, diabetes in women with polycystic ovary syndrome. Diabetes Care 22, 141–146 (1999)CrossRefPubMed D.A. Ehrmann, R.B. Barnes, R.L. Rosenfield, M.K. Cavaghan, J. Imperial, Prevalence of impaired glucose tolerance, diabetes in women with polycystic ovary syndrome. Diabetes Care 22, 141–146 (1999)CrossRefPubMed
6.
Zurück zum Zitat X. Chen, D. Yang, L. Li, S. Feng, L. Wang, Abnormalglucose tolerance in Chinese women with polycystic ovary syndrome. Hum. Reprod. 21, 2027–2032 (2006)CrossRefPubMed X. Chen, D. Yang, L. Li, S. Feng, L. Wang, Abnormalglucose tolerance in Chinese women with polycystic ovary syndrome. Hum. Reprod. 21, 2027–2032 (2006)CrossRefPubMed
7.
Zurück zum Zitat S. Weerakiet, C. Srisombut, P. Bunnag, S. Sangtong, N. Chuangsoongnoen, A. Rojanasakul, Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome. Int. J. Gynaecol. Obstet. 75, 177–184 (2001)CrossRefPubMed S. Weerakiet, C. Srisombut, P. Bunnag, S. Sangtong, N. Chuangsoongnoen, A. Rojanasakul, Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome. Int. J. Gynaecol. Obstet. 75, 177–184 (2001)CrossRefPubMed
8.
Zurück zum Zitat A. Dunaif, K.R. Segal, W. Futterweit, A. Dobrjansky, Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38, 1165–1174 (1989)CrossRefPubMed A. Dunaif, K.R. Segal, W. Futterweit, A. Dobrjansky, Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38, 1165–1174 (1989)CrossRefPubMed
9.
Zurück zum Zitat J. Holte, T. Bergh, C. Berne, L. Berglund, H. Lithell, Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome, normal glucose tolerance. J. Clin. Endocrinol. Metab. 78, 1052–1058 (1994)CrossRefPubMed J. Holte, T. Bergh, C. Berne, L. Berglund, H. Lithell, Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome, normal glucose tolerance. J. Clin. Endocrinol. Metab. 78, 1052–1058 (1994)CrossRefPubMed
10.
Zurück zum Zitat P. Ovesen, J. Moller, H.J. Ingerslev, J.O. Jorgensen, A. Mengel, O. Schmitz, K.G. Alberti, N. Moller, Normal basal, insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 77, 1636–1640 (1993)CrossRefPubMed P. Ovesen, J. Moller, H.J. Ingerslev, J.O. Jorgensen, A. Mengel, O. Schmitz, K.G. Alberti, N. Moller, Normal basal, insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 77, 1636–1640 (1993)CrossRefPubMed
11.
Zurück zum Zitat S. Toprak, A. Yonem, B. Cakir, S. Guler, O. Azal, M. Ozata, A. Corakci, Insulin resistance in nonobese patients with polycystic ovary syndrome. Horm. Res. 55, 65–70 (2001)CrossRefPubMed S. Toprak, A. Yonem, B. Cakir, S. Guler, O. Azal, M. Ozata, A. Corakci, Insulin resistance in nonobese patients with polycystic ovary syndrome. Horm. Res. 55, 65–70 (2001)CrossRefPubMed
12.
Zurück zum Zitat D. Cibula, G. Sindelka, M. Hill, M. Fanta, J. Skrha, J. Zivny, Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin. Hum. Reprod. 17, 76–82 (2002)CrossRefPubMed D. Cibula, G. Sindelka, M. Hill, M. Fanta, J. Skrha, J. Zivny, Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin. Hum. Reprod. 17, 76–82 (2002)CrossRefPubMed
13.
Zurück zum Zitat J. Vrbikova, D. Cibula, K. Dvorakova, S. Stanicka, G. Sindelka, M. Hill, M. Fanta, K. Vondra, J. Skrha, Insulin sensitivity in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 89, 2942–2945 (2004)CrossRefPubMed J. Vrbikova, D. Cibula, K. Dvorakova, S. Stanicka, G. Sindelka, M. Hill, M. Fanta, K. Vondra, J. Skrha, Insulin sensitivity in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 89, 2942–2945 (2004)CrossRefPubMed
14.
Zurück zum Zitat J. Vrbikova, K. Dvorakova, T. Grimmichova, M. Hill, S. Stanicka, D. Cibula, B. Bendlova, L. Starka, K. Vondra, Prevalence of insulin resistance, prediction of glucose intolerance, type 2 diabetes mellitus in women with polycystic ovary syndrome. Clin. Chem. Lab. Med. 45, 639–644 (2007)CrossRefPubMed J. Vrbikova, K. Dvorakova, T. Grimmichova, M. Hill, S. Stanicka, D. Cibula, B. Bendlova, L. Starka, K. Vondra, Prevalence of insulin resistance, prediction of glucose intolerance, type 2 diabetes mellitus in women with polycystic ovary syndrome. Clin. Chem. Lab. Med. 45, 639–644 (2007)CrossRefPubMed
15.
Zurück zum Zitat B. Trolle, F.F. Lauszus, Risk factors for glucose intolerance in Danish women with polycystic ovary syndrome. Acta Obstet. Gynecol. Scand. 84, 1192–1196 (2005)PubMed B. Trolle, F.F. Lauszus, Risk factors for glucose intolerance in Danish women with polycystic ovary syndrome. Acta Obstet. Gynecol. Scand. 84, 1192–1196 (2005)PubMed
16.
Zurück zum Zitat M. Möhlig, J. Spranger, M. Ristow, A.F. Pfeiffer, T. Schill, H.W. Schlösser, L. Moltz, G. Brabant, C. Schöfl, Predictors of abnormal glucose metabolism in women with polycystic ovary syndrome. Eur. J. Endocrinol. 154, 295–301 (2006)CrossRefPubMed M. Möhlig, J. Spranger, M. Ristow, A.F. Pfeiffer, T. Schill, H.W. Schlösser, L. Moltz, G. Brabant, C. Schöfl, Predictors of abnormal glucose metabolism in women with polycystic ovary syndrome. Eur. J. Endocrinol. 154, 295–301 (2006)CrossRefPubMed
17.
Zurück zum Zitat H.J. Wei, R. Young, I.L. Kuo, C.M. Liaw, H.S. Chiang, C.Y. Yeh, Prevalence of insulin resistance and determination of risk factors for glucose intolerance in polycystic ovary syndrome: a cross-sectional study of Chinese infertility patients. Fertil. Steril. 91, 1864–1868 (2009)CrossRefPubMed H.J. Wei, R. Young, I.L. Kuo, C.M. Liaw, H.S. Chiang, C.Y. Yeh, Prevalence of insulin resistance and determination of risk factors for glucose intolerance in polycystic ovary syndrome: a cross-sectional study of Chinese infertility patients. Fertil. Steril. 91, 1864–1868 (2009)CrossRefPubMed
18.
Zurück zum Zitat A. Gambineri, C. Pelusi, E. Manicardi, V. Vicennati, M. Cacciari, A.M. Morselli-Labate, U. Pagotto, R. Pasquali, Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype, associated factors. Diabetes 53, 2353–2358 (2004)CrossRefPubMed A. Gambineri, C. Pelusi, E. Manicardi, V. Vicennati, M. Cacciari, A.M. Morselli-Labate, U. Pagotto, R. Pasquali, Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype, associated factors. Diabetes 53, 2353–2358 (2004)CrossRefPubMed
19.
Zurück zum Zitat WHO Expert Consultation, Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157–163 (2004)CrossRef WHO Expert Consultation, Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157–163 (2004)CrossRef
20.
Zurück zum Zitat S. Dickinson, S. Colagiuri, E. Faramus, P. Petocz, J.C. Brand-Miller, Postprandial hyperglycemia, insulin sensitivity differ among lean young adults of different ethnicities. J. Nutr. 132, 2574–2579 (2002)PubMed S. Dickinson, S. Colagiuri, E. Faramus, P. Petocz, J.C. Brand-Miller, Postprandial hyperglycemia, insulin sensitivity differ among lean young adults of different ethnicities. J. Nutr. 132, 2574–2579 (2002)PubMed
21.
Zurück zum Zitat M. Chandalia, N. Abate, A. Garg, J. Stray-Gundersen, S.M. Grundy, Relationship between generalized, upper body obesity to insulin resistance in Asian Indian men. J. Clin. Endocrinol. Metab. 84, 2329–2335 (1999)CrossRefPubMed M. Chandalia, N. Abate, A. Garg, J. Stray-Gundersen, S.M. Grundy, Relationship between generalized, upper body obesity to insulin resistance in Asian Indian men. J. Clin. Endocrinol. Metab. 84, 2329–2335 (1999)CrossRefPubMed
22.
Zurück zum Zitat H.R. Park, Y. Choi, H.J. Lee, J.Y. Oh, Y.S. Hong, Y.A. Sung, Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome. Diabetes Res. Clin. Pract. 77(Suppl 1), S233–S237 (2007)CrossRefPubMed H.R. Park, Y. Choi, H.J. Lee, J.Y. Oh, Y.S. Hong, Y.A. Sung, Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome. Diabetes Res. Clin. Pract. 77(Suppl 1), S233–S237 (2007)CrossRefPubMed
23.
Zurück zum Zitat American Diabetes Association, Standards of medical care in diabetes—2007. Diabetes Care. 30(Suppl 1), S4–S41 (2007)CrossRef American Diabetes Association, Standards of medical care in diabetes—2007. Diabetes Care. 30(Suppl 1), S4–S41 (2007)CrossRef
24.
Zurück zum Zitat Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81, 19–25 (2004) Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81, 19–25 (2004)
25.
Zurück zum Zitat J.Y. Oh, Y.S. Hong, Y.A. Sung, E. Barrett-Connor, Prevalence factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care 27, 2027–2032 (2004)CrossRefPubMed J.Y. Oh, Y.S. Hong, Y.A. Sung, E. Barrett-Connor, Prevalence factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care 27, 2027–2032 (2004)CrossRefPubMed
26.
Zurück zum Zitat Steering Committee of the Western Pacific Region of the World Health Organization, the International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications Australia Pty Limited, Melbourne, Australia, 2000 Steering Committee of the Western Pacific Region of the World Health Organization, the International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications Australia Pty Limited, Melbourne, Australia, 2000
27.
Zurück zum Zitat World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes and Mellitus. 1999 World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes and Mellitus. 1999
28.
Zurück zum Zitat R.A. DeFronzo, J.D. Tobin, R. Andres, Glucose clamp technique: a method for quantifying insulin secretion, resistance. Am. J. Physiol. 237, E214–E223 (1979)PubMed R.A. DeFronzo, J.D. Tobin, R. Andres, Glucose clamp technique: a method for quantifying insulin secretion, resistance. Am. J. Physiol. 237, E214–E223 (1979)PubMed
29.
Zurück zum Zitat A. Tsujimura, K. Matsumiya, Y. Miyagawa, T. Takao, K. Fujita, S. Takada, M. Koga, A. Iwasa, M. Takeyama, A. Okuyama, Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis. Int. J. Impot. Res. 17, 259–263 (2005)CrossRefPubMed A. Tsujimura, K. Matsumiya, Y. Miyagawa, T. Takao, K. Fujita, S. Takada, M. Koga, A. Iwasa, M. Takeyama, A. Okuyama, Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis. Int. J. Impot. Res. 17, 259–263 (2005)CrossRefPubMed
30.
Zurück zum Zitat A. Vermeulen, L. Verdonck, J.M. Kaufman, A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84, 3666–3672 (1999)CrossRefPubMed A. Vermeulen, L. Verdonck, J.M. Kaufman, A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84, 3666–3672 (1999)CrossRefPubMed
Metadaten
Titel
The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome
verfasst von
Hyejin Lee
Jee-Young Oh
Yeon-Ah Sung
Hyewon Chung
Wha Young Cho
Publikationsdatum
01.10.2009
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2009
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-009-9226-7

Weitere Artikel der Ausgabe 2/2009

Endocrine 2/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.